Hannah M Linden
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 01, 2024
Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing Subtypes.Nicole C Loroña, Megan Othus, Kathleen E Malone
|Nov 29, 2023
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.Nicole C Loroña, Megan Othus, Kathleen E Malone
|Mar 29, 2023
Can Molecular Imaging Find a Path to Navigate Evolving Breast Cancer Treatments?Hannah M Linden, David A Mankoff
|Jul 02, 2022
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer.Kristine Doney, Wendy Leisenring, Hannah Linden
|Aug 24, 2021
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.Perrin E Romine, Lanell M Peterson, Brenda F Kurland
|Oct 23, 2020
Determinants of Guideline-Discordant Breast Cancer Care.Jean A McDougall, Linda S Cook, Mei-Tzu C Tang
Pageof 1
Frequent Collaborators
2 joint publications
Nicole C Loroña
2 joint publications
Megan Othus
2 joint publications
Kathleen E Malone
2 joint publications
Mei-Tzu C Tang
2 joint publications
Christopher I Li
1 joint publications
Kristine Doney
1 joint publications
Wendy Leisenring
1 joint publications
Beti Thompson
1 joint publications
Lanell M Peterson
1 joint publications
David A Mankoff
